A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: A report from the Children's Oncology Group-Reference-Cited by-同舟云学术

A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: A report from the Children's Oncology Group

Published:2009-02 Issue:2 Volume:52 Page:177-181
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Griffin Timothy C.,Weitzman Sheila,Weinstein Howard,Chang Myron,Cairo Mitchell,Hutchison Robert,Shiramizu Bruce,Wiley Joseph,Woods Deborah,Barnich Margaret,Gross Thomas G.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference21 articles.

1. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: It is possible to reduce treatment for the early responding patients;Patte;Blood,2007

2. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents;Cairo;Blood,2007

3. Burkitt's and Burkitt-like lymphoma in children and adolescents: A review of the Children's Cancer Group experience;Cairo;Br J Haematol,2003

4. Phase II study of cytarabine and etoposide in children with refractory or relapsed non-Hodgkin's lymphoma: A study of the French Society of Pediatric Oncology;Gentet;J Clin Oncol,1990

5. Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine, and l-asparaginase, maintenance chemotherapy, and transplantation: Children's Cancer Group Study CCG-5912;Kobrinsky;J Clin Oncol,2001

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incorporating innovative B‐cell targeting therapeutics into a combined‐modality bridging approach followed by timely consolidative haploidentical transplantation to salvage a pediatric patient with relapsed/refractory diffuse large B‐cell lymphoma;Pediatric Blood & Cancer;2024-09-04

2. Therapy for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma in Children, Adolescents, and Young Adults;Journal of the National Comprehensive Cancer Network;2024-07

3. Treatment of refractory cervical burkitt lymphoma: A case report;Asian Journal of Surgery;2024-07

4. Refractory Burkitt Lymphoma: Diagnosis and Interventional Strategies;Blood and Lymphatic Cancer: Targets and Therapy;2024-03

5. The experience of relapsed Burkitt lymphoma treatment with targeted drugs and autologous/allogeneic stem cell transplantation;Oncohematology;2024-01-25